Isovurex

Ezetimibe, the active ingredient in Isovurex, is a cholesterol absorption inhibitor presented as an oral tablet for oral use. It lowers low‑density lipoprotein (LDL) cholesterol by reducing intestinal absorption of dietary and biliary cholesterol, and is indicated for patients with primary hyperlipidemia, heterozygous familial hypercholesterolemia, and other hypercholesterolemia conditions. The drug is typically prescribed as part of a comprehensive lipid‑lowering regimen that may include diet, exercise, and other pharmacotherapies.

GNH USA supplies Isovurex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isovurex (ezetimibe) is used to manage disorders of lipid metabolism, particularly elevated cholesterol levels.

- Hypercholesterolemia: reduces LDL‑cholesterol levels. - Heterozygous familial hypercholesterolemia: lowers cholesterol in genetically predisposed patients. - Primary hyperlipidemia: improves overall lipid profile.

Ezetimibe is generally well tolerated, but patients may experience a range of adverse reactions.

Common Side Effects: - Abdominal pain: mild to moderate discomfort in the stomach area. - Diarrhea: loose stools occurring intermittently. - Fatigue: feeling unusually tired. - Headache: mild to moderate head pain. - Nausea: sensation of needing to vomit. - Joint pain: aching in joints without swelling.

Serious or Rare Side Effects: - Hepatitis: inflammation of the liver requiring medical attention. - Myopathy: muscle weakness or pain, especially when combined with statins. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Elevated liver enzymes: indicating possible liver injury. - Cholestatic jaundice: yellowing of skin and eyes due to bile flow obstruction.

Patients should be aware of specific safety considerations before starting therapy.

- Renal impairment: monitor kidney function and adjust therapy as needed. - Hepatic disease: assess liver enzymes regularly. - Concomitant statin therapy: evaluate risk of myopathy and liver toxicity. - Pregnancy: avoid use unless clearly necessary, as safety data are limited. - Elderly patients: observe for increased sensitivity to adverse effects. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Ezetimibe may interact with several medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Cyclosporine: may increase ezetimibe exposure and risk of side effects. - Gemfibrozil: heightened risk of myopathy when combined with statins. - Antacids (e.g., aluminum or magnesium): can reduce ezetimibe absorption.

Moderate Interactions (Monitor Closely): - Statins: monitor liver enzymes and muscle symptoms. - Warfarin: possible alteration of INR, requiring closer coagulation monitoring. - Bile acid sequestrants: may affect ezetimibe absorption, adjust timing of doses.